Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal down77.050 -2.200 (-2.776%)
Research Report

24/05/2021 10:27

{I-bank focus}Daiwa cuts JD Health (06618) to HK$130.5

[ET Net News Agency, 24 May 2021] Daiwa Research cut its target price for JD Health
International (06618) to HK$130.5 from HK$148.2 but upgraded its rating to "outperform"
from "hold".
The research house highlighted JDH's strong capability in supply chain and digital
marketing, and its determination in strengthening online healthcare services. By
leveraging JD Group's extensive supply chain, national fulfillment networks and DNA in
direct sales, JDH has built a robust supply chain infrastructure for players along the
healthcare value chain.
Daiwa raised its 2021-22 revenue by 5-7% on fast traffic growth and strong growth of the
digital marketing business. (KL)

Remark: Real time quote last updated: 21/10/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.